Sudden Infant Death: Clinical Trials

1 trial for Sudden Infant Death, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Sudden Infant Death: new trials by email Literature Review of Sudden Infant Death trials Research Report on Sudden Infant Death

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome
tividenofusp alfa - Mucopolysaccharidosis II
Phase 1 / Phase 2Active not recruitingDenali Therapeutics Inc.472020-07-162025-08-07

Narrower conditions

Mucopolysaccharidosis II (1)

Broader conditions

Carbohydrate Metabolism, Inborn Errors (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Death (1)  ·  Death, Sudden (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Infant Death (1)  ·  Intellectual Disability (1)  ·  Lysosomal Storage Diseases (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucinoses (1)  ·  Mucopolysaccharidoses (1)

Sponsors

Denali Therapeutics Inc. (1)

Countries

Canada (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Sam Lu, MD (1)

Results publications

PMID 41467650

NIH funding

2019 (1), 2023 (1)